• See if you qualify for the study

  • The next question is about your medication history with the following drugs:

    Conventional DMARDs

    • Arava (leflunomide)
    • Azulfidine (sulfasalazine)
    • Hydroxychloroquine (oral tablet)
    • Leflunomide (oral tablet)
    • Methotrexate LPF sodium (injection)
    • Methotrexate (generic) (oral tablet)
    • Otrexup (methotrexate injection)
    • Plaquenil (hydroxychloroquine)
    • Rasuvo (methotrexate injection)
    • Rheumatrex (methotrexate oral tablet)
    • Sulfasalazine (oral tablet)
    • Trexall (methotrexate oral tablet)
  • The next question is about your medication history with the following drugs:

    Biologic DMARDs (Biologics)

    • Actemra (tociluzumab) (infusion)
    • Cimzia (certolizumab pegol) (self-injection)
    • Enbrel (etanercept) (self-injection)
    • Humira (adalimumab) (self-injection)
    • Kevzara (sarilumab) (injection)
    • Kineret (anakinra) (injection)
    • Orencia (abatacept) (infusion or self-injection)
    • Remicade (infliximab) (infusion)
    • Rituxan (rituximab) (infusion)
    • Simponi (golimumab) (self-injection)
    • Simponi Aria (golimumab) (infusion)
  • The next two questions are about your medication history with the following drugs:

    Targeted Synthetic DMARDs (JAKs)

    • Olumiant (baricitinib) (oral tablet)
    • Rinvoq (upadacitinib) (oral tablet)
    • Xeljanz (tofacitinib) (oral tablet)
    • Xeljanz XR (tofacitinib) (oral tablet)
  • Great, thank you! Based on your responses, you may qualify for participation in the RESET-RA study.

    Please read and acknowledge the disclosure below related to our privacy policy to give us permission to collect your contact information and have a health-care professional contact you to discuss this study.

  • Our health-care professionals are available Monday through Friday between 8 AM and 8 PM Eastern Time from Monday through Friday. When should they call you?

    (All times below are Eastern.)

  • Please provide us with the following information so that a health-care professional can contact you.

  •  -
  • Please submit your survey answers to see if you meet the initial criteria for the study.

  • Should be Empty: